NeuroLogica Corp. releases new CT dose reduction technology: An adaptive post reconstruction filter that significantly lowers image noise on low dose CT scans while preserving spatial and pathological detail
DANVERS, Mass.- NeuroLogica Corporation, the manufacturer of the CereTom portable CT scanner and NeuroFocus High Resolution SPECT, today announced the launch of its Noise/Dose Reduction solution for medical imaging. NeuroLogica’s solution is a new non-linear post-reconstruction filter that reduces image noise while preserving spatial resolution and noise texture.
“This breakthrough technology represents a significant step toward making NeuroLogica’s CereTom portable CT a standard-of-care in critical care & pediatric imaging,” said Dr. Eric M. Bailey, CEO/President of NeuroLogica. “Accumulated exposure to radiation, particularly tied to CT scans, has been a growing topic of public concern. By reducing the dose of CT radiation without sacrificing diagnostic image quality, the CereTom portable CT will provide a significant clinical advantage in diagnosing and treating critical care and pediatric patients. Such a significant reduction in dose provides clinicians more flexible scanning options without the risks typically associated with multiple high resolution scans.”
NeuroLogica’s CT post reconstruction filter was designed to work similar to military synthetic aperture radar systems which attempt to filter out noise while preserving signal quality to thus “see” objects with better contrast resolution. Historically, these types of algorithms are computationally intensive. However, with the advent of faster, inexpensive computers it has now become possible to apply such technology to CT medical images.
“The processed images have superior signal to noise ratio.” Said Dr. Rajiv Gupta, M.D Assistant Radiologist; Department of Neuroradiology for Massachusetts General Hospital. “While the lesions are more visible because of better signal to noise ratio, they are never processed out of the image.”
NeuroLogica will present this unique feature next week at the 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA). For more information or to have a demonstration of this new technology please come to Booth # 6229 (South Hall).
About NeuroLogica
NeuroLogica Corporation, located in the Boston metro area, develops, manufactures and markets innovative medical imaging equipment for healthcare facilities and private practices worldwide. Established in 2004, NeuroLogica’s founders have over 100 years of combined experience in the design, development and manufacturing of imaging systems including ultrasound, CT, PET, radiation therapy and MRI. Corporate information, clinical images, customer stories, etc. can be found on NeuroLogica’s website at
www.neurologica.com.
